We are live on ! Find out more
ENTA icon

Enanta Pharmaceuticals
ENTA

147 hedge funds and large institutions have $1.1B invested in Enanta Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 42 increasing their positions, 71 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

5,408% more call options, than puts

Call options by funds: $2.92M | Put options by funds: $53K

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

33% more capital invested

Capital invested by funds: $827M → $1.1B (+$274M)

2.74% more ownership

Funds ownership: 93.2% → 95.94% (+2.7%)

3% less funds holding

Funds holding: 151 → 147 (-4)

21% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 14

41% less repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 71

Holders
147
Holders Change
-4
Holders Change %
-2.65%
% of All Funds
2.57%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
11
Increased
42
Reduced
71
Closed
14
Calls
$2.92M
Puts
$53K
Net Calls
+$2.87M
Net Calls Change
+$5.26M

Top Buyers

1
First Manhattan
First Manhattan
New York
+$46.3M
2
Northern Trust
Northern Trust
Illinois
+$15.3M
3
SCM
Soleus Capital Management
Connecticut
+$9.02M
4
FFM
Fairmount Funds Management
Pennsylvania
+$6.87M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$3.89M

Top Sellers

1
Invesco
Invesco
Georgia
-$8.65M
2
AC
Armistice Capital
New York
-$8.11M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$6.35M
4
Millennium Management
Millennium Management
New York
-$6.19M
5
BlackRock
BlackRock
New York
-$3.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$204M -$3.8M -76,953 -2%
FCM
2
Farallon Capital Management
California
$113M – – –
AC
3
Armistice Capital
New York
$104M -$8.11M -164,000 -8%
Vanguard Group
4
Vanguard Group
Pennsylvania
$102M -$2.8M -56,656 -3%
State Street
5
State Street
Massachusetts
$60.9M +$895K +18,107 +2%
First Manhattan
6
First Manhattan
New York
$55.1M +$46.3M +936,536 +2,821%
Northern Trust
7
Northern Trust
Illinois
$54.5M +$15.3M +310,246 +48%
KAM
8
Krensavage Asset Management
New York
$53.2M -$142K -2,873 -0.3%
Renaissance Technologies
9
Renaissance Technologies
New York
$43M -$2.03M -41,143 -5%
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$34.7M -$1.68M -33,922 -5%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$19M +$167K +3,384 +1%
FFM
12
Fairmount Funds Management
Pennsylvania
$18M +$6.87M +138,894 +78%
T. Rowe Price Associates
13
T. Rowe Price Associates
Maryland
$14.9M +$462K +9,341 +4%
Jacobs Levy Equity Management
14
Jacobs Levy Equity Management
New Jersey
$14.4M -$284K -5,739 -2%
Acadian Asset Management
15
Acadian Asset Management
Massachusetts
$13.5M -$6.35M -128,372 -35%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$10.4M +$345K +6,969 +4%
GIM
17
Granahan Investment Management
Massachusetts
$10.4M -$848K -17,154 -9%
SCM
18
Soleus Capital Management
Connecticut
$10.4M +$9.02M +182,400 New
Morgan Stanley
19
Morgan Stanley
New York
$9.22M -$691K -13,975 -8%
Charles Schwab
20
Charles Schwab
California
$7.26M +$50.2K +1,015 +0.8%
Principal Financial Group
21
Principal Financial Group
Iowa
$7.2M -$113K -2,292 -2%
HWAM
22
Hennion & Walsh Asset Management
New Jersey
$6.83M -$205K -4,140 -3%
Norges Bank
23
Norges Bank
Norway
$6.25M – – –
Invesco
24
Invesco
Georgia
$6.03M -$8.65M -174,996 -62%
Goldman Sachs
25
Goldman Sachs
New York
$5.81M -$2.03M -41,099 -29%
1
2 3 4 5

ENTA Hedge Fund Activity: Q3 2021 in Review

147 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Enanta Pharmaceuticals (ENTA) for Q3 2021, worth a combined $1.1B — up 33% from $827M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of ENTA and 11 opened new positions — a net loss of 3 holders — while 71 trimmed existing stakes and 42 added.

The largest buyer was First Manhattan, adding an estimated $46.3M. The largest seller was Invesco, cutting an estimated $8.65M.

  • 147 institutional investors held Enanta Pharmaceuticals (ENTA) as of Q3 2021, down from 151 in Q2 2021.
  • Funds reported $1.1B of Enanta Pharmaceuticals stock for Q3 2021, up 33% quarter-over-quarter.
  • 11 funds opened new Enanta Pharmaceuticals positions in Q3 2021 and 14 closed out, a net change of -3 holders.
  • The largest Enanta Pharmaceuticals buyer in Q3 2021 was First Manhattan, an estimated $46.3M added.
  • The largest Enanta Pharmaceuticals seller in Q3 2021 was Invesco, an estimated $8.65M sold.

Based on aggregated 13F filings for Q3 2021.